يعرض 1 - 10 نتائج من 203 نتيجة بحث عن '"Silvennoinen, Raija"', وقت الاستعلام: 0.69s تنقيح النتائج
  1. 1
  2. 2
    مؤتمر
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المساهمون: Department of Oncology, ATG - Applied Tumor Genomics, Department of Medical and Clinical Genetics, HUS Comprehensive Cancer Center, Hematologian yksikkö, Research Programs Unit, Institute for Molecular Medicine Finland, Helsinki Institute of Life Science HiLIFE, Digital Precision Cancer Medicine (iCAN), Clinicum, HUS Diagnostic Center, HUSLAB

    مصطلحات موضوعية: 3122 Cancers

    وصف الملف: application/pdf

    العلاقة: Hakkarainen , M , Koski , J R , Heckman , C A , Anttila , P , Silvennoinen , R , Lievonen , J , Kilpivaara , O & Wartiovaara-Kautto , U 2022 , ' A germline exome analysis reveals harmful POT1 variants in multiple myeloma patients and families ' , eJHaem , vol. 3 , no. 4 , pp. 1352-1357 . https://doi.org/10.1002/jha2.557Test; ORCID: /0000-0001-8467-2100/work/156157846; http://hdl.handle.net/10138/355173Test; 0fc40e1b-10a0-43d1-9351-f227c703b45e

  6. 6
  7. 7
    دورية أكاديمية

    المصدر: Transfusion Medicine and Hemotherapy ; volume 50, issue 5, page 438-447 ; ISSN 1660-3796 1660-3818

    مصطلحات موضوعية: Hematology, Immunology and Allergy

  8. 8
  9. 9
    دورية أكاديمية

    المساهمون: Institute for Molecular Medicine Finland, HUS Comprehensive Cancer Center, Hematologian yksikkö, HUS Head and Neck Center, Department of Oncology

    وصف الملف: application/pdf

    العلاقة: CT/PD acknowledge the Q-Exactive quantitative mass spectrometer was funded under the Research Infrastructure Call 2012 by Science Foundation Ireland (SFI-12/RI/2346/3). CT acknowledges Dr. Dean Frawley for proof reading this manuscript. DB/POG acknowledge funding from the Irish Cancer Society (BCN18OGO). POG acknowledges funding from the Irish Cancer Society (CRA17OGO).; Tierney , C , Bazou , D , Majumder , M M , Anttila , P , Silvennoinen , R , Heckman , C A , Dowling , P & O'Gorman , P 2021 , ' Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients ' , Scientific Reports , vol. 11 , 12866 . https://doi.org/10.1038/s41598-021-90149-yTest; ORCID: /0000-0002-5550-2951/work/107670467; 70866d6e-1b44-4520-b74e-c94f0e873691; http://hdl.handle.net/10138/339456Test; 000665061400002

  10. 10
    دورية أكاديمية

    المساهمون: Institute for Molecular Medicine Finland, Helsinki Institute of Life Science HiLIFE, Digital Precision Cancer Medicine (iCAN), Hematologian yksikkö, HUS Comprehensive Cancer Center, Department of Oncology, University of Helsinki

    مصطلحات موضوعية: 3122 Cancers

    وصف الملف: application/pdf

    العلاقة: This work has been supported by funding from Oncopeptides, the iCAN Digital Precision Cancer Medicine Flagship (Academy of Finland grant 1320185), Cancer Society of Finland, and Sigrid Juselius Foundation. Open Access funding provided by University of Helsinki including Helsinki University Central Hospital.; Kumari , R , Majumder , M M , Lievonen , J , Silvennoinen , R , Anttila , P , Nupponen , N N , Lehmann , F & Heckman , C A 2021 , ' Prognostic significance of esterase gene expression in multiple myeloma ' , British Journal of Cancer , vol. 124 , no. 8 , pp. 1428-1436 . https://doi.org/10.1038/s41416-020-01237-1Test; ORCID: /0000-0002-5550-2951/work/108068740; 5eeaacaf-8e57-495a-8fac-54d10f2b162f; http://hdl.handle.net/10138/340172Test; 000613998200005